DealMaker Recognized on Deloitte’s Technology Fast 50 List

November 7, 2024

Toronto, November 7, 2024 — DealMaker, the leading platform for online capital-raising, is thrilled to announce its inclusion in Deloitte’s 2024 Technology Fast 50 list, securing the #13 spot in Canada’s foremost ranking of the country’s fastest-growing technology companies. This achievement marks DealMaker’s second year on one of Deloitte’s prestigious lists, highlighting its continued commitment to revolutionizing the capital-raising landscape and accelerating growth for visionary founders.

‍

Deloitte’s Technology Fast 50 program celebrates companies that lead in technology innovation, entrepreneurial spirit, rapid revenue growth, and bold advancements that drive meaningful change. Over the past year, DealMaker has made a significant impact in the financial technology sector, empowering companies of all sizes to raise capital online and transform their communities into strategic growth engines.

‍

“Earning a spot on Deloitte’s Technology Fast 50 list is a testament to our team’s unwavering dedication to innovation and to our customers, who trust DealMaker as a strategic partner in their growth journey,” said Rebecca Kacaba, CEO and co-founder of DealMaker. “We’re proud to offer solutions that make raising capital more accessible and efficient for companies at all stages. This recognition validates our mission to redefine fundraising and establish online retail capital raising as the new standard.”

‍

DealMaker’s solutions have powered some of North America’s largest online capital raises, allowing companies to engage with a wide-reaching audience, align brand loyalty with investment, and drive growth by turning investors into stakeholders. As the capital markets continue to evolve, DealMaker remains at the forefront, helping visionary founders unlock new avenues for growth through the power of retail and community-driven capital.

‍

About DealMaker

‍

DealMaker is the premier technology platform for online capital-raising, helping companies transform their investor communities into powerful growth assets. Led by a team of seasoned capital markets experts, DealMaker empowers companies to raise capital online with unprecedented ease, transparency, and efficiency. With a proven track record powering some of the largest online raises in North America, DealMaker is setting the standard for the future of online capital markets.

‍

About the Deloitte Technology Fast 50 program

‍

The Deloitte Technology Fast 50 program is Canada’s premier technology awards program. It recognizes business growth, innovation, and entrepreneurship in four distinct categories: Technology Fast 50, Enterprise Industry Leaders, Clean Technology, and Companies-to-Watch. The program also honors technology companies in the United States and Canada in partnership with the North American Technology Fast 500 program. For more information, visit www.fast50.ca.

‍

Media Contact:

Bianca Roses
bianca@rosespr.com

‍

Monogram Case Study - DealMaker (Embed)

When VCs said no, Monogram turned to retail investors. That decision powered their rise from startup to publicly traded company—and even helped them raise an additional $13M privately after their Nasdaq debut.

The Challenge: Raising Capital on Their Terms

The Challenge: Raising on Their Terms

Monogram Technologies was founded with a bold vision: to revolutionize orthopedic surgery with a robotic joint replacement system using custom 3D-printed joints. The market for this technology is massive—approximately $19.6 billion, with over 1 million knee replacements per year. But it's a capital-intensive, regulation-heavy space—and traditional VCs weren't biting.

Instead of compromising, co-founders Dr. Doug Unis and Ben Sexson went all-in on a different path: retail capital. Why?

Control and ownership: Not only were they able to raise the capital they needed to grow the business—they did it on their own terms.
Long-term asset: They wanted to build an army of true believers who wanted to see the company succeed and would continue to reinvest over the years.
A value-add network: Raising from retail allowed Monogram to amass a waiting list of thousands of patients eager to participate in future trials.
Aligned incentives: Their mission to improve patient outcomes and build a better future for those struggling with joint pain resonated with retail investors.

The Power of Retail: Monogram's Capital Journey

Start Date	End Date	Type	Platform	Amount Raised	# Investors
3/13/19	3/31/20	A+	SeedInvest	$14,588,668	6,000
11/16/20	1/16/21	A+	StartEngine	$2,965,501	8,000
1/17/21	2/18/22	A+	StartEngine	$23,647,853	14,082
7/15/22	3/16/23	CF	DealMaker	$4,673,000	2,249
3/1/23	4/8/23	A+	Republic	$232,275	120
3/1/23	5/23/23	A+	DealMaker	$15,958,364	5,198
5/18/23	-	Nasdaq listing
7/24	10/24	Unit Offering	DealMaker	$12,990,103	2,745

Monogram Capital Raise Timeline

Monogram's first direct-to-investor raise was a $14.6M round in 2019. Since then, Monogram has raised retail capital six additional times, using Reg A+ as a springboard to a Nasdaq listing in 2023.

Each raise brought in new believers—and more importantly, kept bringing them back. That's the long-term power of retail capital. It's not just one campaign—it's a compounding asset that grows with the business.

$80M+

Raised across seven campaigns

~40,000

Investors championing Monogram's vision

20%

Of each raise came from previous investors

Marketing Excellence

DealMaker Reach provided strategic investor acquisition services, helping Monogram connect with the right audience through high-impact channels.

Premium Publications

Targeted campaigns in premium publications like Morning Brew captured qualified investors

High-Engagement Webinars

Engaging events that generated over $4.3 million in investments

Community Building

Strategic approaches that fostered a loyal shareholder base

Investment Momentum

Innovative approaches that amplified investment momentum

Monogram's Journey to Success

Monogram's journey has been defined by relentless innovation, strategic fundraising, and breakthrough advancements in robotic-assisted joint replacement. From early-stage research to a Nasdaq listing and beyond, Monogram's milestones reflect its evolution into a pioneering force in orthopedic surgery:

Filed its first patent application in 2017
Conducted clinical studies at UCLA and University of Nebraska
Expanded the team with key hires
Attracted a top-tier advisory board to guide clinical innovations
Signed their first distribution partnerships
Made headlines with cutting-edge live demonstrations
Secured 501(k) FDA clearance for the mBôs surgical system

Nasdaq Debut & Beyond

In May 2023, Monogram Orthopaedics successfully listed on the Nasdaq—a significant milestone offering liquidity and growth opportunities for the company.

For most companies, that would be the end of their story in the private markets. But for Monogram, it was just the beginning of a new chapter.

Public perception says you can't raise privately post-IPO. Monogram proved that wrong.

Defying conventional fundraising norms, Monogram raised an additional $13 million from private investors, powered by DealMaker. This move highlighted the power of a dedicated investor community and provided additional strategic growth capital. Meanwhile, strategic digital marketing for the private offering helped boost the public share price—a win-win for the company and its investors, both public and private.

This was retail capital at its best: strategic, repeatable, and aligned.

One vision. Zero compromises.

This wasn't a one-time raise. It was a multi-year capital strategy.

Retail capital helped Monogram:

Go from concept to commercialization without relying on VCs
Retain ownership and control in a high-burn industry
Build a base of loyal shareholders who invested not once, but over and over again
Uplist to the Nasdaq, and still keep raising post-IPO

This is what makes retail capital different. It doesn't expire—it compounds. And DealMaker is built to maximize that long-term value.

Ready to Raise Capital on Your Terms?

Whether you're pre-revenue or post-IPO, DealMaker gives you the infrastructure, support, and strategy to raise from the people who believe in you most.

Explore Raising Capital with DealMaker